Man Group’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $54.5M | Buy |
758,865
+304,865
| +67% | +$23.5M | 0.1% | 225 |
|
|
2025
Q4 | $36M | Sell |
454,000
-169,534
| -27% | -$13.4M | 0.06% | 310 |
|
|
2025
Q3 | $47M | Sell |
623,534
-902,478
| -59% | -$61.8M | 0.08% | 272 |
|
|
2025
Q2 | $105M | Buy |
1,526,012
+1,321,068
| +645% | +$86.6M | 0.2% | 113 |
|
|
2025
Q1 | $13.9M | Sell |
204,944
-635,870
| -76% | -$38.1M | 0.04% | 592 |
|
|
2024
Q4 | $37.7M | Buy |
840,814
+586,270
| +230% | +$32.9M | 0.1% | 238 |
|
|
2024
Q3 | $16M | Buy |
254,544
+180,963
| +246% | +$10.6M | 0.04% | 530 |
|
|
2024
Q2 | $4.35M | Buy |
73,581
+7,267
| +11% | +$455K | 0.01% | 1055 |
|
|
2024
Q1 | $5.29M | Sell |
66,314
-659,526
| -91% | -$50.4M | 0.01% | 973 |
|
|
2023
Q4 | $57.3M | Buy |
+725,840
| New | +$51.7M | 0.16% | 139 |
|
|
2023
Q3 | – | Sell |
-1,964,801
| Closed | -$139M | – | 71 |
|
|
2023
Q2 | $136M | Buy |
+1,964,801
| New | +$140M | 0.42% | 35 |
|
|
2023
Q1 | – | Sell |
-1,089,095
| Closed | -$91.3M | – | 27 |
|
|
2022
Q4 | $101M | Sell |
1,089,095
-348,231
| -24% | -$33.6M | 0.36% | 46 |
|
|
2022
Q3 | $137M | Buy |
+1,437,326
| New | +$142M | 0.64% | 17 |
|
|
2022
Q2 | – | Sell |
-731,091
| Closed | -$71.4M | – | 20 |
|
|
2022
Q1 | $74M | Buy |
731,091
+226,375
| +45% | +$23.8M | 0.26% | 81 |
|
|
2021
Q4 | $52.1M | Buy |
504,716
+139,438
| +38% | +$12.9M | 0.17% | 124 |
|
|
2021
Q3 | $31M | Sell |
365,278
-168,321
| -32% | -$14.1M | 0.11% | 209 |
|
|
2021
Q2 | $44.5M | Buy |
533,599
+163,172
| +44% | +$13.4M | 0.16% | 145 |
|
|
2021
Q1 | $27.9M | Buy |
370,427
+186,855
| +102% | +$13.6M | 0.12% | 174 |
|
|
2020
Q4 | $12.5M | Sell |
183,572
-112,607
| -38% | -$7.32M | 0.06% | 369 |
|
|
2020
Q3 | $17.3M | Buy |
296,179
+122,885
| +71% | +$7.65M | 0.07% | 307 |
|
|
2020
Q2 | $11.3M | Buy |
173,294
+72,654
| +72% | +$4.58M | 0.06% | 324 |
|
|
2020
Q1 | $5.97M | Sell |
100,640
-192,684
| -66% | -$12.9M | 0.04% | 450 |
|
|
2019
Q4 | $21.8M | Buy |
293,324
+239,879
| +449% | +$16.8M | 0.07% | 324 |
|
|
2019
Q3 | $3.37M | Sell |
53,445
-84,638
| -61% | -$5.02M | 0.01% | 1048 |
|
|
2019
Q2 | $7.52M | Buy |
138,083
+31,191
| +29% | +$1.68M | 0.03% | 767 |
|
|
2019
Q1 | $5.76M | Sell |
106,892
-479,633
| -82% | -$29.6M | 0.02% | 838 |
|
|
2018
Q4 | $38.4M | Buy |
586,525
+422,860
| +258% | +$31.6M | 0.17% | 126 |
|
|
2018
Q3 | $12.9M | Sell |
163,665
-1,515
| -0.9% | -$108K | 0.05% | 500 |
|
|
2018
Q2 | $10.6M | Buy |
165,180
+62,498
| +61% | +$4.12M | 0.04% | 558 |
|
|
2018
Q1 | $6.39M | Buy |
+102,682
| New | +$7.37M | 0.03% | 718 |
|
Other funds holding CVS
VCM
VPM
Man Group's CVS Position: Q1 2026 in Review
Man Group increased its CVS Health (CVS) stake by 67% in Q1 2026, buying an estimated $23.5M and bringing the position to 758,865 shares worth $54.5M. The position accounts for 0.1% of the portfolio, ranked #225.
Man Group first reported a position in CVS in Q1 2018 and has held it in 30 quarters since. The position peaked at $137M in Q3 2022. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Man Group held 758,865 shares of CVS Health worth $54.5M as of Q1 2026.
- Man Group bought 304,865 CVS Health shares in Q1 2026, an estimated $23.5M.
- CVS Health made up 0.1% of Man Group's portfolio in Q1 2026, its #225 holding.
- Man Group first reported a position in CVS Health in Q1 2018 and has held it in 30 quarters since.
- Man Group's CVS Health position peaked at $137M in Q3 2022.
- 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.